NCT01755338

Brief Summary

The purpose of this study is to investigate if methylprednisolone is effective in reducing the cerebral inflammatory response after open heart surgery with cardiopulmonary bypass.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

December 18, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 24, 2012

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

June 1, 2017

Status Verified

May 1, 2017

Enrollment Period

4.2 years

First QC Date

December 18, 2012

Last Update Submit

May 31, 2017

Conditions

Keywords

cerebrospinal fluidinflammatory markersheart surgeryneuronal damageblood brain barrier

Outcome Measures

Primary Outcomes (1)

  • Changes in cerebrospinal fluid (CSF) levels of IL-6, IL-8, S100B, alb

    24h after surgery

Secondary Outcomes (1)

  • Postoperative/intraoperative insulin demand

    24h after surgery

Study Arms (2)

Methylprednisolone

ACTIVE COMPARATOR

Methylprednisolone i.v. 15mg/kg x 1 intraoperative Aortic Valve Replacement

Drug: Methylprednisolone

Placebo (NaCl)

PLACEBO COMPARATOR

Placebo i.v., x1, intraoperative Aortic Valve Replacement

Drug: Placebo

Interventions

Methylprednisolone 15mg/kg

Also known as: Solu-Medrol
Methylprednisolone

Placebo

Also known as: Sodium Chloride
Placebo (NaCl)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective aortic surgery +/- coronary artery bypass grafting (CABG)

You may not qualify if:

  • coagulopathy
  • preoperative neurologic deficit
  • uncontrolled hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital

Gothenburg, VGR, 41345, Sweden

Location

Related Publications (1)

  • Danielson M, Reinsfelt B, Westerlind A, Zetterberg H, Blennow K, Ricksten SE. Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial. J Neuroinflammation. 2018 Sep 27;15(1):283. doi: 10.1186/s12974-018-1318-y.

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

MethylprednisoloneMethylprednisolone HemisuccinateSodium Chloride

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

PrednisolonePregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Sven-Erik Ricksten, Professor

    Sahlgrenska University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 18, 2012

First Posted

December 24, 2012

Study Start

December 1, 2012

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

June 1, 2017

Record last verified: 2017-05

Locations